Article Sidebar

PDF
Date Published: 27/10/2023
Abstract Views: 284
Views PDF: 181
DOI: https://doi.org/10.51298/vmj.v531i1.6960
Issue
Vol. 531 No. 1 (2023)
Section
Các bài báo
How to Cite
Phạm , T. D. L. ., Lê, V. T. ., Phạm , Đức M. ., & Nguyễn , D. Đông . (2023). PREVALENCE AND FACTORS ASSOCIATED WITH SARCOPENIA IN PATIENTS ON MAINTENANCE HEMODIALYSIS. Vietnam Medical Journal, 531(1). https://doi.org/10.51298/vmj.v531i1.6960

PREVALENCE AND FACTORS ASSOCIATED WITH SARCOPENIA IN PATIENTS ON MAINTENANCE HEMODIALYSIS

Thị Diệu Linh Phạm 1, Việt Thắng Lê2, Đức Minh Phạm 2, Duy Đông Nguyễn 2,
1 Vietnam Military Medical Academy
2 103 Military Hospital

Main Article Content

Abstract

Aims: We investigated the prevalence of sarcopenia in patients with maintenance hemodialysis (MHD) and its relationship with various factors. Patients and methods: A cross-sectional study was conducted with 79 patients having MHD aged over 18 years in Department of Nephrology and Dialysis, Militaty Hospital 103. Sarcopenia was defined as a decline in skeletal muscle mass index and handgrips strengh and/or physical performed acording to AWGS 2019 diagnosis criteria. Results: The mean age was 54.7 ± 15.1 years; 51.9% were men and 20.3% had diabetes. Sarcopenia was associated with body mass index, and calf circumference, serum cholesterol level. Multivariate logistic regression analysis found that and low body mass index was an independent risk factor for sarcopenia in patients with MHD. Conclusions: The frequency of sarcopenia in patients with MHD accounts for 19,0%. Low body mass index is an independent risk factor for sarcopenia in MHD patients.

Article Details

Keywords

sarcopenia, hemodialysis

References

1. Fahal I.H (2013), "Uraemic sarcopenia: aetiology and implications", Nephrology Dialysis Transplantation 29(9), pp. 1655-1665.
2. Đỗ Thị Tư (2018), Sarcopenia và một số yếu tố liên quan ở bệnh nhân cao tuổi có bệnh thận mạn, Luân văn Thạc sỹ Y học, Đại học Y Hà Nội.
3. Chen L-K, Woo J, Assantachai P et al. (2020), "Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment", Journal of the American Medical Directors Association 21(3), pp. 300-307. e2.
4. Dorosty A, Arero G, Chamar M et al. (2016), "Prevalence of sarcopenia and its association with socioeconomic status among the elderly in Tehran", Ethiopian journal of health sciences 26(4), pp. 389-396.
5. Sharma D, Hawkins M & Abramowitz M.K (2014), "Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States", Clinical journal of the American Society of Nephrology: CJASN 9(12), pp. 2079.
6. Mattera M, Veronese N, Aucella F et al. (2021), "Prevalence and risk factors for sarcopenia in chronic kidney disease patients undergoing dialysis: a cross-sectional study", Turk J Nephrol 30(pp. 294-299.
7. Isoyama N, Qureshi A.R, Avesani C.M et al. (2014), "Comparative associations of muscle mass and muscle strength with mortality in dialysis patients", Clinical Journal of the American Society of Nephrology 9(10), pp. 1720-1728.